Publications for Mark Gillies
2021 Nguyen, V., Puzo, M., Sanchez-Monroy, J., Gabrielle, P., Sheth, J., Gopal, L., Gillies, M., Khatri, M., Kuppermann, B., Garcher, C., Baudin, F., Wolff, B., Castelnovo, L., Michel, G., Roy, R., Chawla, S., Rajendran, A., Narayanan, R. (2021). O'Toole, L., Barthelmes, D., Gillies, M. (2021). Vitreoretinal Society of India practice pattern survey 2020: ASSOCIATION BETWEEN ANATOMICAL AND Medical retina. Indian Journal of Ophthalmology, 69(6), 1430- CLINICAL OUTCOMES OF NEOVASCULAR AGE- 1439. [More ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR. Information] Retina, 41(7), 1446-1454. [Mor 2020 e Information] Ang, J., Ah-Moye, S., Kim, L., Nguyen, V., Hunt, A., Salem, W., Zagora, S., Nguyen, V., Mehta, H., Gillies, M., Barthelmes, D., Gillies, M., Mehta, H. (2020). A systematic Fraser-Bell, S. (2021). Effect of intravitreal injection speed on review of real-world evidence of the management of macular acute rise in intraocular pressure. The SPEED IOP study. oedema secondary to branch retinal vein occlusion. Eye, 34(10), Clinical and Experimental Ophthalmology, 49(5), 519-521. [More 0861-9">[More Information] Information] Gibson, A., Humphries, J., Gillies, M., Nassar, N., Colagiuri, S. Cornish, E., Teo, K., Nguyen, V., Squirrel, D., Gillies, M., (2020). Adherence to eye examination guidelines among Barthelmes, D. (2021). FIVE-YEAR INCIDENCE AND individuals with diabetes: An analysis of linked health data. VISUAL ACUITY OUTCOMES FOR INTRAVITREAL Clinical and Experimental Ophthalmology, 48(9), 1229-1238. THERAPY IN BILATERAL NEOVASCULAR AGE- [More RELATED MACULAR DEGENERATION: Fight Retinal Information] Blindness! Project. Retina, 41(1), 118-124. [Mor Arnold, J., Young, S., Barthelmes, D., Gillies, M. (2020). e Information] Assessing The Accuracy Of A Large Observational Registry Of Zhang, R., Engel, A., Wang, Y., Li, B., Shen, W., Gillies, M., Neovascular Age-Related Macular Degeneration. Retina, 40(5), Chao, J., Du, J. (2021). Inhibition of Mitochondrial Respiration 866-872. [Mor Human Retinal Pigment Epithelium. Journal of Proteome e Information] Research, 20(1), 909-922. [More Fraser-Bell, S., Mehta, H., Gillies, M., Barthelmes, D. (2020). Information] Changes in real-world treatment patterns for diabetic macular Cornish, E., Nguyen, V., Young, S., Fraser-Bell, S., Guymer, oedema from 2009 to 2019 and 5-year outcomes: Data from the R., Squirrell, D., Barthelmes, D., Gillies, M. (2021). Fight Retinal Blindness! Registry. Clinical and Experimental Neovascular age-related macular degeneration at treatment Ophthalmology, 48(6), 802-812. [More Ophthalmology, 49(6), 570-578. href="http://dx.doi.org/10.1111/ceo.13962">[More Chong Teo, K., Saxena, N., Gan, A., Wong, T., Gillies, M., Information] Chakravarthy, U., Cheung, C. (2020). Detrimental Effect of Invernizzi, A., Parrulli, S., Monteduro, D., Cereda, M., Nguyen, Delayed Re-treatment of Active Disease on Outcomes in V., Staurenghi, G., Cheung, C., Gillies, M., Teo, K. (2021). Neovascular Age-Related Macular Degeneration: The RAMPS Outer Retinal Layer Thickening Predicts the Onset of Exudative Study. Ophthalmology Retina, 4(9), 871-880. [More Journal of Ophthalmology, 231, 19-27. href="http://dx.doi.org/10.1016/j.ajo.2021.05.015">[More Shah, J., Vaze, A., Tang Lee Say, T., Gillies, M., Fraser-Bell, S. Information] (2020). Emerging corticosteroid delivery platforms for Too, L., Shen, W., Mammo, Z., Osaadon, P., Gillies, M., treatment of diabetic macular edema. Expert Opinion on Simunovic, M. (2021). Surgical Retinal Explants as a Source of Emerging Drugs, 25(4), 383-394. [Mor href="http://dx.doi.org/10.1097/IAE.0000000000003137">[Mor e Information] e Information] Freude, K., McCauley, A., Paterson, C., Odette, M., Oostenink, Figueras-Roca, M., Parrado-Carrillo, A., Nguyen, V., Casaroli- A., Hyttel, P., Haukedal, H., Saruhanian, S., Kolko, M., Gillies, Marano, R., Moll-Udina, A., Gillies, M., Barthelmes, D., M. (2020). Enrichment of retinal ganglion and Muller glia Zarranz-Ventura, J. (2021). Treat-and-extend versus fixed progenitors from retinal organoids derived from human induced bimonthly treatment regimens for treatment-naive neovascular pluripotent stem cells - possibilities and current limitations. age-related macular degeneration: real world data from the World Journal of Stem Cells, 12(10), 1171-1183. [More and Experimental Ophthalmology, 259(6), 1463-1470. href="http://dx.doi.org/10.1007/s00417-020-05016-9">[More Wiryasaputra, S., Nguyen, V., Arnold, J., Ferrier, R., Information] Hinchcliffe, P., Barthelmes, D., Gillies, M. (2020). Four-week M., Ceklic, L., Gillies, M., Barthelmes, D. (2020). Prevalence outcomes of vascular endothelial growth factor inhibitors for and characteristics of macular atrophy in eyes with neovascular neovascular age-related macular degeneration. Clinical and age-related macular degeneration. A study from a long-term Experimental Ophthalmology, 48(7), 946-955. [More British Journal of Ophthalmology, 104(8), 1064-1069. href="http://dx.doi.org/10.1136/bjophthalmol-2019- 315055">[More Information] Gabrielle, P., Nguyen, V., Wolff, B., Essex, R., Young, S., Hunt, A., Gemmy Cheung, C., Milne, E., Barthelmes, D., Teo, K., Joe, A., Nguyen, V., Invernizzi, A., Milne, E., Creuzot-Garcher, C., Gillies, M. (2020). Intraocular Pressure Barthelmes, D., Gillies, M. (2020). PREVALENCE AND RISK Changes and Vascular Endothelial Growth Factor Inhibitor Use FACTORS FOR THE DEVELOPMENT OF PHYSICIAN- in Various Retinal Diseases: Long-Term Outcomes in Routine GRADED SUBRETINAL FIBROSIS IN EYES TREATED Clinical Practice: Data from the Fight Retinal Blindness! FOR NEOVASCULAR AGE-RELATED MACULAR Registry. Ophthalmology Retina, 4(9), 861-870. [More href="http://dx.doi.org/10.1097/IAE.0000000000002779">[Mor Information] e Information] Finger, R., Puth, M., Schmid, M., Barthelmes, D., Guymer, R., Bhandari, S., Nguyen, V., Fraser-Bell, S., Mehta, H., Viola, F., Gillies, M. (2020). Lifetime Outcomes of Anti-Vascular Baudin, F., Gabrielle, P., Creuzot-Garcher, C., Gillies, M., Endothelial Growth Factor Treatment for Neovascular Age- Barthelmes, D. (2020). Ranibizumab or Aflibercept for Diabetic Related Macular Degeneration. Archives of Ophthalmology, Macular Edema: Comparison of 1-Year Outcomes from the 138(12), 1234-1240. [ 615. href="http://dx.doi.org/10.1016/j.ophtha.2019.11.018">[More Information] Fung, A., Tran, T., Lim, L., Samarawickrama, C., Arnold, J., Gillies, M., Catt, C., Mitchell, L., Symons, A., Robert, B., Gillies, M. (2020). Register your interest. Clinical and Tumuluri, K., et al (2020). Local delivery of corticosteroids in Experimental Ophthalmology, 48(4), 421-423. [More Ophthalmology, 48(3), 366-401. href="http://dx.doi.org/10.1111/ceo.13702">[More Gillies, M., Nguyen, C., Nguyen, V., Daien, V., Cohn, A., Information] Banerjee, G., Arnold, J. (2020). Reply. Ophthalmology, 127(4), Gillies, M., Hunyor, A., Arnold, J., Guymer, R., Wolf, S., e21-e22. [More in Neovascular Age-Related Macular Degeneration: A Information] Randomized Clinical Trial Comparing Ranibizumab and Zhang, R., Shen, W., Du, J., Gillies, M. (2020). Selective Aflibercept (RIVAL Study). Ophthalmology, 127(2), 198-210. knockdown of hexokinase 2 in rods leads to age-related [More Cell Death and Disease, 11(10), 1-15. href="http://dx.doi.org/10.1038/s41419-020-03103-7">[More Li, B., Zhang, T., Liu, W., Wang, Y., Xu, R., Zeng, S., Zhang, Information] R., Zhu, S., Gillies, M., Zhu, L., et al (2020). Metabolic Vittorio, A., Nguyen, V., Barthelmes, D., Arnold, J., Cheung, Features of Mouse and Human Retinas: Rods versus Cones, C., Murray, N., Gillies, M. (2020). SMOKING STATUS AND Macula versus Periphery, Retina versus RPE. iScience, 23(11), TREATMENT OUTCOMES OF VASCULAR 101672. [More NEOVASCULAR AGE-RELATED MACULAR Information] DEGENERATION. Retina, 40(9), 1696-1703. [Mor Barthelmes, D., Gillies, M. (2020). Outcomes of cataract e Information] surgery in eyes with diabetic macular oedema: Data from the Fan, J., Shen, W., Lee, S., Mathai, A., Zhang, R., Xu, G., Fight Retinal Blindness! Registry. Clinical and Experimental Gillies, M. (2020). Targeting the Notch and TGF-β Ophthalmology, 48(4), 462-469.